Anxiety and Depression Symptoms and Every-Night Sleep Medication Use in Older Adults

2019 ◽  
Vol 34 (7) ◽  
pp. 449-455 ◽  
Author(s):  
Jonathan H. Watanabe ◽  
Diane L. Chau
2019 ◽  
Vol 34 (7) ◽  
pp. 449-455
Author(s):  
Jonathan H. Watanabe ◽  
Diane L. Chau

OBJECTIVE: To quantify relationship between anxiety and depression symptoms with every-night sleep medication use in the United States. DESIGN: A case-control analysis to measure association between subjects with anxiety and depression symptoms and sleep medication use. SETTING AND PATIENTS: Older adults (N = 7,590) from the National Health and Aging Trends Study. MAIN OUTCOME MEASURE: Sleep medication use every night. RESULTS: Presence of the four anxiety and depression symptoms was associated with nightly sleep medication use. Those who reported "felt down, depressed, or hopeless" almost every day had an odds ratio (OR) of 3.50 (95% confidence interval [CI] 2.28-5.37) compared with those who did not. Those who reported "little interest or pleasure in doing things" almost every day had an OR of 1.86 (95% CI 1.32-2.61) compared with those with symptoms less often. Those who reported "felt nervous, anxious, or on edge" more than half the days had an OR of 3.43 (95% CI 2.68-4.37) compared with those who experienced the symptom less frequently. Those who reported "unable to stop or control worrying" more than half the days had an OR of 2.91 (95% CI 2.25-3.77) compared with those who did not. CONCLUSION: Older adults with anxiety and depression are more likely to use sleep medications every night. Efforts must be undertaken to reduce anxiety and depression to mitigate excess consumption of sedatives.


2021 ◽  
Vol 9 ◽  
pp. 205031212110400
Author(s):  
Kemal Jemal ◽  
Tinsae Abeya Geleta ◽  
Berhanu Senbeta Deriba ◽  
Mukemil Awol

Objectives: The coronavirus disease 2019 pandemic has caused high morbidity and mortality in older adults over the world. Because the coronavirus disease 2019 pandemic greatly affects older adults who have a preexisting health condition, they are generally susceptible to a high incidence of severe symptoms of anxiety and depression. Therefore, we aimed to assess the prevalence of anxiety and depression symptoms in older adults during the coronavirus disease 2019 pandemic. Methods: Community-based cross-sectional study was completed in August 2020. Standardized and pretested General Anxiety Disorder–7 and Geriatric Depression Scale were used to screen the symptoms of anxiety and depression, respectively. Data were entered into EpiData (version 4.3.2) and transferred to SPSS (version 24) for further analysis. Bivariate and multivariate logistic regression analyses were carried out to determine the significantly associated variables with a 95% confidence interval at p < 0.05. Results: Of the total older adults interviewed, 68.7% had developed symptoms of anxiety and 59.9% had symptoms of depression during the coronavirus disease 2019 pandemic. Female participants, having a chronic disease and poor knowledge of the coronavirus disease 2019 pandemic, were significantly associated with anxiety symptoms. Age category of 81 to 90 and above 90, lack of social support, and having a chronic disease were significantly associated with symptoms of depression. Conclusion: The symptoms of anxiety and depression among older adults in the North Shoa Zone during coronavirus disease 2019 were higher than before the coronavirus disease 2019 happened. The results were evidence points for developing a psychological intervention to tackle the older adults’ mental health needs in the community during and after the coronavirus disease 2019 pandemic.


2015 ◽  
Vol 27 (9) ◽  
pp. 1523-1532 ◽  
Author(s):  
Viviana M. Wuthrich ◽  
Carly J. Johnco ◽  
Julie L. Wetherell

ABSTRACTBackground:Anxiety and depression symptoms change over the lifespan and older adults use different terms to describe their mental health, contributing to under identification of anxiety and depression in older adults. To date, research has not examined these differences in younger and older samples with comorbid anxiety and depression.Methods:One hundred and seven treatment-seeking participants (47 older, 60% female, and 60 younger, 50% female) with anxiety and mood disorders completed the Anxiety Disorders Interview Schedule and a symptom checklist to examine differences in symptom severity, symptom profiles and terms used to describe anxiety and mood.Results:The findings indicated several key differences between the presentation and description of anxiety and depression in younger and older adults. Older adults with Social Phobia reported fearing a narrower range of social situations and less distress and interference. Older adults with Generalized Anxiety Disorder (GAD) reported less worry about interpersonal relationships and work/school than younger adults, however, there were no differences between age groups for behavioral symptoms endorsed. Further older adults reported phobia of lifts/small spaces more frequently than younger adults. Depressed older depressed adults also reported more anhedonia compared to younger adults, but no differences in terms of reported sadness were found. Finally, older and younger adults differed in their descriptions of symptoms with older adults describing anxiety as feeling stressed and tense, while younger adults described anxiety as feeling anxious, worried or nervous.Conclusions:Clinicians need to assess symptoms broadly to avoid missing the presence of anxiety and mood disorders especially in older adults.


2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. 197-197
Author(s):  
Alexandra Wennberg ◽  
Loretta Anderson

Abstract Difficulty with sleep and falls are prevalent among older adults. Sleep medication use is associated with falls in older adults, but little is known about its impact in older adults with dementia. We used data from the 2011 National Health and Aging Trends Study to assess the association of low- versus high- frequency sleep medication use with falls in older adults with self-reported dementia. In our fully adjusted model, among those with dementia, high-frequency sleep medication users were more likely to fall than low-frequency sleep medication users (OR=3.86, 95% CI: 1.31, 11.37). Among those without dementia, high-frequency sleep medication users were more likely to fall than low-frequency sleep medication users (OR=1.40, 95% CI: 1.11, 1.77). Reducing sleep medication use in older adults with and without dementia may help reduce the risk of falls and fall-related outcomes in older adults.


SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A189-A189
Author(s):  
V Dokkedal-Silva ◽  
M M Oliveira ◽  
J F Galduroz ◽  
S Tufik ◽  
M L Andersen

Abstract Introduction Use of medications to treat sleep complaints is a common practice that may incur in cognitive deficits. Evidence, beyond the well-described effects of benzodiazepines on cognition, still needs expansion. This study assessed the use of sleep aid medications of different classes and associated factors on prospective and retrospective memory in a representative populational sample from São Paulo. Methods Volunteers in the EPISONO study underwent evaluation through questionnaires and a complete polysomnography exam. A subsample of 500 volunteers (Mean Age=42.9 years; 307 women) was included. Users (N=250) and non-users (N=250; randomly selected among the non-using volunteers) of sleep medication were evaluated regarding scores in 8 subscales and the overall score of the Prospective and Retrospective Memory Questionnaire (PRMQ). Afterwards, users of classes of medications were compared. Covariates, including scores in psychiatric evaluation scales and polysomnographic findings, were added in both segments to identify the factors with highest interference in the results obtained. Results Medication users consistently performed worse in prospective memory and short-term internal-cued retrospective memory even when covariates were added. Scores in Beck Anxiety and Depression Inventories, Insomnia Severity Index and variables related to wakefulness and sleep architecture were the covariates with the highest interference in the results. When comparing types of medication, few differences were seen, suggesting that for such analysis, a sample with higher power would be appropriate. Conclusion Users of sleep medication presented impairment in prospective memory. Factors such as sleep architecture and continuity, as well as insomnia, anxiety and depression symptoms must be considered when evaluating cognitive deficits and pharmacological treatment in patients with sleep complaints, as they may participate in this relationship. Future studies are necessary to characterize the impact of different medication classes on prospective and retrospective memory. Support Our studies are supported by Associação Fundo de Incentivo à Pesquisa (AFIP) and Conselho Nacional de Desenvolvimento Científico Tecnológico (CNPq - Grant #133397/2017-3); S.T. and M.L.A. received CNPq fellowships.


2019 ◽  
Vol 15 ◽  
pp. P523-P524
Author(s):  
Yue Leng ◽  
Katie L. Stone ◽  
Kristine Yaffe

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. 1006-1006
Author(s):  
Erta Cenko ◽  
Christopher Kaufmann ◽  
Todd Manini

Abstract At the beginning of the COVID-19 pandemic, consuming media was critical to identify precautionary behaviors to reduce the spread of the virus, particularly for older adults. Media consumption leads to heightened awareness, but may also negatively affect mental health. We examined whether non-social and social media consumption impacted anxiety and depression relative to pre-COVID-19 symptoms. We conducted an anonymous, cross-sectional survey in May and June 2020. Participants (n=1,168, 73.2 years, 56.8% women, 94.9% White), were asked to estimate their amount of time spent consuming pandemic-related media each day, and to report on anxiety and depressive symptoms both before and after the pandemic onset. We characterized change in anxiety and depression by subtracting scores on current anxiety and depressive symptoms from their recalled symptoms prior to the pandemic. Respondents with high pandemic-related media consumption (&gt;3hrs) were more likely to have increased anxiety, compared to those with low (&lt;1hr) media consumption (OR:1.57, 95%CI:1.09-2.23). Similarly, respondents with increased social media consumption during the pandemic were 64% more likely to have depression, compared to those who did not use social media. This association was bi-directional— those who reduced their social media use were 45% less likely to have depression and 26% less likely to have anxiety, compared to those who never used social media. Older adults consuming more pandemic-related media had increased anxiety. Increased social media consumption was associated with elevated depression symptoms. The potential benefits of media consumption about the COVID-19 pandemic may have unintended negative consequences on mental health.


2020 ◽  
Author(s):  
Rebecca Robbins ◽  
Ralph J. DiClemente ◽  
Andrea B. Troxel ◽  
Girardin Jean-Louis ◽  
Mark Butler ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document